Effects of bariatric surgery on obesity associated gastroesophageal reflux disease: Insights from a systematic review and network meta-analysis

Table 3 Surface under the cumulative ranking curve ranking table presenting the probabilities of each surgery being ranked for each outcome

Outcomes	Rank	1	2	3	4	5
Body mass index reduction	OAGB	1.61%	44.33%	32.52%	13.73%	7.82%
	OAGBantiflux	88.63%	4.66%	2.68%	2.06%	1.97%
	RYGB	6.30%	40.17%	44.64%	6.86%	2.04%
	SG	1.28%	6.37%	15.23%	67.62%	9.50%
	SGantiflux	2.19%	4.47%	4.94%	9.73%	78.67%
Percent excess weight loss	OAGB	91.00%	7.45%	1.27%	0.29%	-
	RYGB	3.03%	78.64%	14.01%	4.33%	-
	SG	0.81%	5.34%	64.39%	29.47%	-
	SGantiflux	5.16%	8.58%	20.34%	65.92%	-
GERD remission	OAGB	0.00%	0.22%	0.50%	71.59%	27.69%
	OAGBantiflux	0.01%	0.14%	0.28%	27.79%	71.78%
	RYGB	99.99%	0.01%	0.00%	0.00%	0.00%
	SG	0.00%	93.61%	6.26%	0.12%	0.02%
	SGantiflux	0.00%	6.03%	92.96%	0.50%	0.51%
GERD onset	OAGB	13.99%	21.40%	64.24%	0.37%	0.00%
	OAGBantiflux	0.16%	0.43%	1.76%	38.40%	59.24%
	RYGB	0.00%	0.00%	0.14%	59.24%	40.62%
	SG	31.69%	54.52%	13.40%	0.40%	0.00%
	SGantiflux	54.16%	23.65%	20.45%	1.60%	0.14%
Change in Proton pump inhibitor usage	OAGB	13.22%	25.75%	31.91%	29.12%	-
	RYGB	1.34%	16.80%	46.09%	35.77%	-
	SG	67.47%	26.74%	5.16%	0.63%	-
	SGantiflux	17.97%	30.71%	16.85%	34.48%	-
Change in esophagitis	OAGB	2.98%	5.14%	16.60%	75.29%	-
	RYGB	34.43%	40.61%	18.14%	6.82%	-
	SG	51.39%	39.37%	8.67%	0.58%	-
	SGantiflux	11.20%	14.88%	56.60%	17.31%	-
Complication	OAGB	1.29%	69.35%	17.62%	11.30%	0.44%
	OAGBantiflux	0.26%	3.41%	3.07%	2.51%	90.75%
	RYGB	0.08%	15.07%	47.82%	33.82%	3.21%
	SG	0.01%	10.86%	31.27%	52.27%	5.59%
	SGantiflux	98.36%	1.31%	0.23%	0.09%	0.01%

GERD: Gastroesophageal reflux disease; OAGB: One-anastomosis gastric bypass; RYGB: Roux-en-Y gastric bypass; SG: Sleeve gastrectomy.